Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does SECUKINUMAB Cause C-reactive protein increased? 2,224 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 2,224 reports of C-reactive protein increased have been filed in association with SECUKINUMAB (COSENTYX). This represents 1.5% of all adverse event reports for SECUKINUMAB.

2,224
Reports of C-reactive protein increased with SECUKINUMAB
1.5%
of all SECUKINUMAB reports
958
Deaths
1,282
Hospitalizations

How Dangerous Is C-reactive protein increased From SECUKINUMAB?

Of the 2,224 reports, 958 (43.1%) resulted in death, 1,282 (57.6%) required hospitalization, and 884 (39.7%) were considered life-threatening.

Is C-reactive protein increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 2,224 reports have been filed with the FAERS database.

What Other Side Effects Does SECUKINUMAB Cause?

Drug ineffective (27,434) Psoriasis (21,976) Pain (15,244) Arthralgia (13,769) Fatigue (9,406) Psoriatic arthropathy (8,900) Pruritus (8,755) Malaise (8,570) Rash (8,023) Condition aggravated (7,536)

What Other Drugs Cause C-reactive protein increased?

METHOTREXATE (5,999) ADALIMUMAB (4,579) RITUXIMAB (4,060) ETANERCEPT (3,922) TOCILIZUMAB (3,719) INFLIXIMAB (3,621) LEFLUNOMIDE (3,574) HYDROXYCHLOROQUINE (3,552) ABATACEPT (3,451) SULFASALAZINE (3,096)

Which SECUKINUMAB Alternatives Have Lower C-reactive protein increased Risk?

SECUKINUMAB vs SELADELPAR LYSINE SECUKINUMAB vs SELEGILINE SECUKINUMAB vs SELENIUM SECUKINUMAB vs SELENIUM SULFIDE SECUKINUMAB vs SELEXIPAG

Related Pages

SECUKINUMAB Full Profile All C-reactive protein increased Reports All Drugs Causing C-reactive protein increased SECUKINUMAB Demographics